Market Report: “Biosynthesis of Cannabinoids: Vanguard of The Bio Revolution”

September 23rd, 2020|

Biosynthesis is the production of molecules by living organisms. Engineers have learned to harness these powerful biological systems to produce specific materials for humanity’s benefit. By engineering the instructions for materials’ production into the genetic code of simple organisms—e.g. bacteria, algae, yeast and other fungi—they can acquire the novel ability to produce molecules they usually wouldn’t. A cornerstone technology of the bio revolution.

Renew Biopharma Inc CEO on Developing Biosynthetic Cannabinoid Therapeutics for TBI

April 25th, 2019|

Renew Biopharma Inc is a research company developing proprietary therapeutics to treat neurodegenerative diseases, traumatic brain injuries (TBI), and for pain management. CEO Mike Mendez provides an introduction to the company and explains its interest in developing treatments using biosynthetic cannabinoids.

Next Gen Cannabinoids for Clinical Neurology

Contact Us

General Inquiries: info@renewbiopharma.com

Press Inquiries: press@renewbiopharma.com

Contact Us